Baht 2,896,834,342 to Baht 2,348,135,754 by cancelling 548,698,588 shares at a par value of Baht 1.00 per share. As such shares are the remaining shares which reserved for the existing shareholders by
total investment value of THB 8,771.4mn. May 1) Paid dividend from retained earnings at the rate of THB 0.015 per share to shareholders whose name appeared on the share register book on 9 May 2019 (Record
, increased by 7.20% compared to last year. As a result, the Company reported net profit of Baht 65.98 million, decreased by 30.23% from last year. Earnings per share presented at Baht 3.09. Statement of
decrease 21.54%, due to decrease in bank loan. 7. Share of profit (loss) from investment in associated company In Q2/2018, Share of profit (loss) from investment in associated company was Baht 10.75 million
million compare with the same period of previous year amount to Baht 14.77 million, decrease by Baht 1.46 million or decrease 9.91%, as a result of the company has appropriate expenses control. 5. Loss from
Limited. (“ERV”) shall invest to purchase the newly issued ordinary share of ERV by 24,999 shares at the price of Baht 100 per share, total investment value is Baht 2,499,900 (par value of Baht 100 per
Revolution Company Limited. (“ERV”) shall invest to purchase the newly issued ordinary share of ERV by 24,999 shares at the price of Baht 100 per share, total investment value is Baht 2,499,900 (par value of
on paid-up capital 305.53 305.53 - 0.00% Share surplus from business combination under common control 20.64 20.64 - 0.00% Retained earnings 53.19 80.98 (27.79) (34.32%) Other component of equity 81.85
Company has been awarded ISO 13485, the Quality Management System for Medical Device Industry which is an important tool for competition and maintaining the product’s market share), the Company can maintain
Profit (Loss) (16.93) (2.20) 14.73 669.55 Earnings per share (Baht per share) (0.0032) (0.0005) 0.0027 540.00 Net Profit (Loss) The Company and subsidiaries (Consolidated) realized net loss of 16.93